The Microbiome

Right now, your body is home to over 100 trillion microorganisms. They live on your skin, in your mouth, in your lungs, and most densely in your gut. Collectively, the genes carried by these microbes outnumber the genes in your own human genome by more than 100 to 1. You are, in a very real sense, more microbial than human. The human microbiome is the community of bacteria, viruses, fungi, and archaea that live on and inside you, and scientists are only just beginning to understand how deeply it affects your health, your immune system, and even your mood.

The Human Superorganism: Understanding the Commensal Microbiota

The term "microbiome" refers to the entire collection of microorganisms (and their collective genetic material) that inhabit a particular environment. When people say "the microbiome" without further qualification, they usually mean the human gut microbiome, because the gastrointestinal tract hosts the largest and most diverse microbial community in the body. The gut microbiota (the organisms themselves, as opposed to the "microbiome" which also includes their genes and metabolites) is dominated by bacteria from two major phyla: Firmicutes and Bacteroidetes. But it also includes smaller populations of archaea, fungi, and viruses (including bacteriophages that infect the gut bacteria).

Your microbiome is as unique to you as your fingerprint. It begins to form at birth (influenced by whether you are delivered vaginally or by caesarean section) and is shaped throughout life by diet, geography, medication use, and environmental exposure. No two people have exactly the same microbial community, and the composition of your microbiome can shift significantly in response to dietary changes, illness, or antibiotic use.

Symbiotic Functions: Metabolic Pathways, Gut-Brain Axis, and Immune Training

The gut microbiome performs several essential functions. It breaks down dietary fibers and complex carbohydrates that human enzymes cannot digest, fermenting them into short-chain fatty acids (like butyrate) that nourish the cells lining the colon. It synthesizes certain vitamins, including vitamin K and several B vitamins. It trains the immune system during early life, helping it learn the difference between harmless organisms and genuine pathogens. And it provides colonization resistance, a defensive function where the established microbial community physically and chemically blocks pathogenic bacteria from gaining a foothold in the gut.

The gut-brain axis is one of the most exciting areas of microbiome research. The gut and brain communicate through the vagus nerve, the immune system, and microbial metabolites. Early research suggests that the composition of the gut microbiome can influence mood, anxiety, and stress responses. Studies in animal models have shown that germ-free mice (raised without any microbiome) show altered behavior and stress responses, and that these changes can be partially reversed by introducing specific bacterial species. Scientists are still working out exactly how this connection operates in humans, but the evidence that the gut and brain are in constant conversation through microbial intermediaries is growing rapidly.

Dysbiosis is the term for an imbalanced or disrupted microbiome. It has been linked to a growing list of conditions, including inflammatory bowel disease (IBD), type 2 diabetes, obesity, colorectal cancer, and depression. One of the clearest clinical examples of dysbiosis is Clostridioides difficile infection. When broad-spectrum antibiotics wipe out the normal gut bacteria, C. difficile, which forms hardy endospores that survive antibiotic treatment, can overgrow and cause severe diarrhea and colitis. Fecal microbiota transplantation (FMT), in which a healthy donor's stool is transplanted into the patient's gut to restore normal microbial diversity, has proven remarkably effective at treating recurrent C. difficile infections. Two FMT-based products have received FDA approval for this purpose.

Scientists study the microbiome using molecular tools rather than traditional bacterial culture, because most gut microbes cannot be grown in a standard lab. 16S rRNA gene sequencing targets a specific gene found in all bacteria and archaea, using sequence variations to identify which species are present in a sample. Metagenomics goes further, sequencing all the DNA in a sample to catalog not just which organisms are present but what genes they carry and what functions they might be performing. In 2024, researchers at the University of Cambridge used these methods to identify a group of gut bacteria called CAG-170 that is consistently associated with good health across diverse populations.

Dysbiosis and Pathophysiology: Fecal Transplants and Chronic Inflammatory Disease

The microbiome is reshaping how we think about health and disease. Conditions that were once thought to have purely genetic or lifestyle causes, such as obesity and depression, may have a microbial component. The success of FMT for C. difficile has opened the door to exploring microbiome-based therapies for other conditions. Probiotics, prebiotics, and even precisely engineered microbial cocktails are being studied as potential treatments for everything from IBD to metabolic syndrome.

For clinicians, understanding the microbiome has changed how they think about antibiotic use. Every course of antibiotics disrupts the gut microbiome, and in some patients, that disruption has lasting consequences. This is another reason antimicrobial stewardship matters: preserving the patient's microbiome is now recognized as an important consideration alongside treating the immediate infection.

Clinical Scenario: Clostridioides difficile Colitis and Restoration of Gut Health

An elderly patient finishes a two-week course of broad-spectrum antibiotics for a urinary tract infection. A week later, she develops severe watery diarrhea, abdominal cramping, and a low-grade fever. Stool testing is positive for C. difficile toxin. She is treated with vancomycin, but the infection comes back twice. After the third recurrence, her doctors recommend FMT. A processed stool sample from a screened healthy donor is administered via colonoscopy. Within days, her symptoms resolve. Her gut microbiome, restored by the transplanted community of healthy bacteria, re-establishes colonization resistance and suppresses the C. difficile overgrowth.

Essential Microbiome Terminology